Parya Saberi, PharmD, MAS, MFA

Faculty

Parya Saberi, PharmD, MAS, MFA, AAHIVP is an Associate Professor at the Division of Prevention Science in the Department of Medicine at the University of California, San Francisco (UCSF) and the Director of the UCSF Center for AIDS Prevention Studies Developmental Core. Dr. Saberi is funded by the National Institutes of Health and the Centers for Disease Control and Prevention. Her research aims to improve healthcare by removing barriers related to finances, transportation, work schedule, childcare, ability, and stigma, by offering interventions to individuals at their place of residence or other convenient locations (i.e., outside of a traditional clinical setting). She has received numerous grants to develop interventions including technology-based solutions to improve HIV treatment and prevention care continuums. Additionally, she is involved in several projects focused on increasing pre-exposure prophylaxis uptake from pharmacies, as well as research in Iran and Lebanon. Finally, Dr. Saberi is an expert clinical consultant for the CDC/HRSA-funded National Clinician Consultation Center (HIV Warmline, PEPline, PrEPline, and Perinatal HIV Hotline), which has the mission of promoting health equity in the US by supporting healthcare professionals through evidenced-informed, person-centered clinical consultation and education.

Education
06/2024 - Psychedelic-Assisted Therapies and Research Certificate Program, California Institute for Integral Studies
MFA, 06/2021 - Master’s in Fine Arts, Saint Mary’s College of California
Fellowship, 06/2012 - , University of California, San Francisco
MAS, 06/2011 - Master's in Clinical Research, University of California, San Francisco
06/2006 - HIV Specialty Pharmacy Residency, University of California, San Francisco
06/2005 - Clinical Pharmacy Residency, Montefiore Medical Center
PharmD, 06/2004 - , Massachusetts College of Pharmacy
Websites
Publications

  1. Bakre S, Chang HY, Doshi JA, Goedel WC, Saberi P, Chan PA, Nunn A, Dean LT. Clinician Specialty and HIV PrEP Prescription Reversals and Abandonments. JAMA internal medicine 2024. PMID: 39158923


  2. Stoner MCD, Smith L, Ming K, Mancuso N, Patani H, Sukhija-Cohen A, Granados Y, Wagner D, Johnson MO, Napierala S, Neilands TB, Saberi P. Results from a pilot study of an automated directly observed therapy intervention using artificial intelligence with conditional economic incentives among young adults with HIV. Journal of acquired immune deficiency syndromes (1999) 2024. PMID: 38363868


  3. Parya Saberi, Hoa Su, Julian Mendiola, Cristina Gruta, Erin R. Lutes, Betty Dong, Chris Bositis, Carolyn Chu. HIV pre-exposure prophylaxis champion preceptorship training for pharmacists and nurses in the United States. Journal of Urology 2024. PMID:


  4. Dean LT, Nunn AS, Chang HY, Bakre S, Goedel WC, Dawit R, Saberi P, Chan PA, Doshi JA. Estimating The Impact Of Out-Of-Pocket Cost Changes On Abandonment Of HIV Pre-Exposure Prophylaxis. Health affairs (Project Hope) 2024. PMID: 38190604


  5. Stoner MCD, Ming K, Wagner D, Smith L, Patani H, Sukhija-Cohen A, Johnson MO, Napierala S, Neilands TB, Saberi P. Youth Ending the HIV Epidemic (YEHE): Protocol for a pilot of an automated directly observed therapy intervention with conditional economic incentives among young adults with HIV. PloS one 2023. PMID: 38134037


  6. Saberi P, Stoner MCD, McCuistian CL, Balaban C, Ming K, Wagner D, Chakraborty B, Smith L, Sukhija-Cohen A, Neilands TB, Gruber VA, Johnson MO. iVY: protocol for a randomised clinical trial to test the effect of a technology-based intervention to improve virological suppression among young adults with HIV in the USA. BMJ open 2023. PMID: 37802624


  7. Becker N, Kim HC, Bright DJ, Williams Iii R, Anguera JA, Arnold EA, Saberi P, Neilands TB, Pollack LM, Tan JY. Acceptability of the LetSync App Wireframes for an mHealth Intervention to Improve HIV Care Engagement and Treatment Among Black Partnered Sexual Minority Men: Findings from In-Depth Qualitative Interviews. JMIR formative research 2023. PMID: 37624634


  8. Sauceda JA, Campbell CK, Ndukwe SO, Dubé K, Saberi P. Medical mistrust of health systems as a moderator of resilience and self-reported HIV care engagement in Black and Latinx young adults living with HIV. Cultural diversity & ethnic minority psychology 2023. PMID: 37589681


  9. Sauceda JA, Dubé K, Harris O, Campbell CK, Ndukwe S, Saberi P. The influence of the COVID-19 pandemic on the physical, social, and mental health of Black and Latinx young people with HIV in the United States. Journal of acquired immune deficiency syndromes (1999) 2023. PMID: 36913727


  10. Campbell CK, Dub? K, Sauceda JA, Sevelius JM, Green-Ajufo B, Brown B, Ndukwe S, Saberi P. Cash Transfer Apps are a Feasible, Acceptable, and More Equitable Method for Compensating Participants in HIV Research. Journal of acquired immune deficiency syndromes (1999) 2023. PMID: 36976553


  13. Maragh-Bass AC, Stoner M, Castellanos-Usigli A, Agarwal H, Katz A, Patani H, Sukhija-Cohen A, Campbell L, Arreola S, Saberi P. New PrEP options need different counseling approaches: reframing 'risk' in HIV prevention counseling for young sexual and gender minorities (YSGM) of color. AIDS (London, England) 2023. PMID: 37070546


  14. Saberi P, Stoner MCD, Eskaf S, Ndukwe S, Campbell CK, Sauceda JA, Dubé K. Preferences for HIV Treatment Formulations among Young Adults with HIV in the United States. Journal of acquired immune deficiency syndromes (1999) 2022. PMID: 36343377


  16. Sahota H, Guzman S, Tordera L, Chan M, Cocohoba J, Saberi P. Pharmacy Deserts and Pharmacies' Roles Post-Extreme Weather and Climate Events in the United States: A Scoping Review. Journal of primary care & community health 2023. PMID: 37431885


  17. Dubé K, Campbell CK, Eskaf S, Sauceda JA, Ndukwe S, Henley L, Persaud D, Deeks SG, Auerbach JD, Saberi P. Willingness of Racially Diverse Young Adults Living with HIV to Participate in HIV Cure Research: A Cross-Sectional Survey in the United States. AIDS research and human retroviruses 2022. PMID: 36226414


  18. Campbell CK, Ndukwe S, Dub? K, Sauceda JA, Saberi P. Overcoming Challenges of Online Research: Measures to Ensure Enrollment of Eligible Participants. Journal of acquired immune deficiency syndromes (1999) 2022. PMID: 36094490


  19. Epstein A, Nagata JM, Ganson KT, Nash D, Saberi P, Tsai AC, Charlebois ED, Weiser SD. Drought, HIV Testing, and HIV Transmission Risk Behaviors: A Population-Based Study in 10 High HIV Prevalence Countries in Sub-Saharan Africa. AIDS and behavior 2022. PMID: 36066761


  21. Stoner MCD, Maragh-Bass AC, Sukhija-Cohen AC, Saberi P. Digital directly observed therapy to monitor adherence to medications: a scoping review. HIV research & clinical practice 2022. PMID: 35904111


  22. Saberi P, Mehtani NJ, Sayegh A, Camp CE, Chu C. Understanding HIV Pre-Exposure Prophylaxis Questions of U.S. Health Care Providers: Unique Perspectives from the PrEPline Clinical Teleconsultation Service. Telemedicine journal and e-health : the official journal of the American Telemedicine Association 2022. PMID: 35802493


  24. Saberi P, Stoner MCD, Ming K, Lisha NE, Hojilla JC, Scott HM, Liu AY, Steward WT, Johnson MO, Neilands TB. The effect of an HIV pre-exposure prophylaxis (PrEP) panel management strategy to increase PrEP prescriptions. AIDS (London, England) 2022. PMID: 35730363


  25. Shrestha I, Ming K, Jimenez V, Wendelborn J, Vazquez A, Steward W, Scott HM, Saberi P. Lessons learned from an HIV pre-exposure prophylaxis coordination program in San Francisco primary care clinics. TO REMOVE 2022. PMID: 35592996


  27. Hojilla JC, Gandhi M, Satre DD, Johnson MO, Saberi P. Equity in access to long-acting injectables in the USA. TO REMOVE 2022. PMID: 35131041


  29. Miall A, McLellan R, Dong K, Ndung'u T, Saberi P, Sauceda JA, Dubé K. Bringing social context into global biomedical HIV cure-related research: An urgent call to action. TO REMOVE 2021. PMID: 35169489


  30. Arnold EA, Saberi P, Wong JO, Pollack LM, Neilands TB, Benjamin M, Lockett G, Kegeles SM. We are Family: A Feasibility and Acceptability Study of an HIV Prevention Intervention With the House Ball and Gay Family Communities. TO REMOVE 2021. PMID: 34757987


  31. Saberi P, Campbell C, Lee EY, Guzman J, McCormack-Sharp MM, Dube K. Illustrating HIV Cure Research Strategies for the Next Generation of Research Participants: A Research-Community Collaboration. TO REMOVE 2021. PMID: 34779679


  32. Campbell CK, Dubé K, Sauceda JA, Ndukwe S, Saberi P. Antiretroviral therapy experience, satisfaction, and preferences among a diverse sample of young adults living with HIV. TO REMOVE 2021. PMID: 34793253


  33. Kim HC, Pollack LM, Saberi P, Neilands TB, Arnold EA, Bright DJ, Williams RW, Kegeles SM, Tan JY. Study protocol: a pilot randomised waitlist-controlled trial of a dyadic mobile health intervention for black sexual-minority male couples with HIV in the USA. BMJ open 2021. PMID: 34475191


  34. Saberi P, Lisha NE, Erguera XA, Hudes ES, Johnson MO, Ruel T, Neilands TB. A Mobile Health App (WYZ) for Engagement in Care and Antiretroviral Therapy Adherence Among Youth and Young Adults Living With HIV: Single-Arm Pilot Intervention Study. JMIR formative research 2021. PMID: 34463622


  35. Dubé K, Kanazawa J, Taylor J, Dee L, Jones N, Roebuck C, Sylla L, Louella M, Kosmyna J, Kelly D, Clanton O, Palm D, Campbell DM, Onaiwu MG, Patel H, Ndukwe S, Henley L, Johnson MO, Saberi P, Brown B, Sauceda JA, Sugarman J. Ethics of HIV cure research: an unfinished agenda. BMC medical ethics 2021. PMID: 34193141


  36. Dubé K, Kanazawa J, Campbell C, Boone CA, Maragh-Bass AC, Campbell DM, Agosto-Rosario M, Stockman JK, Diallo DD, Poteat T, Johnson M, Saberi P, Sauceda JA. Considerations for Increasing Racial, Ethnic, Gender, and Sexual Diversity in HIV Cure-Related Research with Analytical Treatment Interruptions: A Qualitative Inquiry. AIDS research and human retroviruses 2021. PMID: 33947268


  37. Camp C, Saberi P. Facilitators and barriers of 2-1-1 HIV pre-exposure prophylaxis. PloS one 2021. PMID: 34014998


  38. Saberi P, Ming K, Hojilla JC, Scott HM, Neilands TB. HIV Preexposure Prophylaxis in the Time of COVID-19: How a Robust and Responsive HIV Preexposure Prophylaxis Intervention Can Avert Loss of HIV Prevention Coverage During a Global Pandemic. Journal of acquired immune deficiency syndromes (1999) 2021. PMID: 33534275


  39. Lisha NE, Neilands TB, Erguera XA, Saberi P. Development of the Mobile Technology Vulnerability Scale among Youth and Young Adults Living with HIV. International journal of environmental research and public health 2021. PMID: 33920803


  40. McCuistian C, Wootton AR, Legnitto-Packard D, Gruber VA, Dawson-Rose C, Johnson MO, Saberi P. Addressing HIV care, mental health and substance use among youth and young adults in the Bay Area: description of an intervention to improve information, motivation and behavioural skills. BMJ open 2021. PMID: 38058024


  41. Saberi P, Campbell CK, Venegas M, Dubé K. Time to Engage Young People in HIV Cure Research. AIDS research and human retroviruses 2021. PMID: 33677996


  42. Dubé K, Kanazawa J, Dee L, Taylor J, Campbell DM, Brown B, Johnson MO, Saberi P, Sauceda JA, Sugarman J, Peluso MJ. Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research. HIV research & clinical practice 2021. PMID: 33757411


  43. Saberi P, McCuistian C, Agnew E, Wootton AR, Legnitto Packard DA, Dawson-Rose C, Johnson MO, Gruber VA, Neilands TB. Video-Counseling Intervention to Address HIV Care Engagement, Mental Health, and Substance Use Challenges: A Pilot Randomized Clinical Trial for Youth and Young Adults Living with HIV. Telemedicine reports 2021. PMID: 33575683


  44. Kanazawa JT, Saberi P, Sauceda JA, Dubé K. The LAIs Are Coming! Implementation Science Considerations for Long-Acting Injectable Antiretroviral Therapy in the United States: A Scoping Review. AIDS research and human retroviruses 2020. PMID: 33176429


  45. Saberi P, Ming K, Scott H, Liu A, Steward W. "You can't have a PrEP program without a PrEP Coordinator": Implementation of a PrEP panel management intervention. PloS one 2020. PMID: 33064763


  46. Dubé K, Willenberg L, Dee L, Sylla L, Taylor J, Roebuck C, Palm D, Campbell D, Newton L, Patel H, Perry KE, Kanazawa J, Gerrard J, Brown B, Saberi P, Sauceda JA, Peluso MJ. Re-examining the HIV 'functional cure' oxymoron: Time for precise terminology? Journal of virus eradication 2020. PMID: 33251025


  47. Sauceda JA, Neilands TB, Lightfoot M, Saberi P. Findings from a probability-based survey of U.S. households about prevention measures based on race, ethnicity, and age in response to SARS-CoV-2. The Journal of infectious diseases 2020. PMID: 32860499


  49. Dube K, Campbell DM, Perry KE, Kanazawa JT, Saberi P, Sauceda JA, Poteat T, Evans D. Reasons People Living with HIV Might Prefer Oral Daily Antiretroviral Therapy, Long-Acting Formulations, or Future HIV Remission Options. AIDS research and human retroviruses 2020. PMID: 32829645


  50. Dubé K, Perry KE, Mathur K, Lo M, Javadi SS, Patel H, Concha-Garcia S, Taylor J, Kaytes A, Dee L, Campbell D, Kanazawa J, Smith D, Gianella S, Auerbach JD, Saberi P, Sauceda JA. Altruism: Scoping review of the literature and future directions for HIV cure-related research. Journal of virus eradication 2020. PMID: 33294210


  52. Ming K, Shrestha I, Vazquez A, Wendelborn J, Jimenez V, Lisha N, Neilands TB, Scott H, Liu A, Steward W, Johnson MO, Saberi P. Improving the HIV PrEP continuum of care using an intervention for healthcare providers: a stepped-wedge study protocol. BMJ open 2020. PMID: 32665393


  53. Koester KA, Saberi P, Fuller SM, Arnold EA, Steward WT. Attitudes about community pharmacy access to HIV prevention medications in California. Journal of the American Pharmacists Association : JAPhA 2020. PMID: 32665097


  54. Saberi P, Eskaf S, Sauceda J, Evans D, Dube K. Perceptions of HIV Virologic Control Strategies among Younger and Older Age Groups of People Living with HIV in the United States: A Cross-Sectional Survey. AIDS research and human retroviruses 2020. PMID: 32368934


  55. Saberi P, Scott HM. On-Demand Oral Pre-exposure Prophylaxis with Tenofovir/Emtricitabine: What Every Clinician Needs to Know. Journal of general internal medicine 2020. PMID: 31965523


  56. Saberi P, Chakravarty D, Ming K, Legnitto D, Gandhi M, Johnson MO, Neilands TB. Moving Antiretroviral Adherence Assessments to the Modern Era: Correlations Among Three Novel Measures of Adherence. AIDS and behavior 2019. PMID: 31758349


  57. Dube K, Eskaf S, Evans D, Sauceda J, Saberi P, Brown B, Averitt D, Martel K, Meija M, Campbell D, Barr L, Kanazawa J, Perry K, Patel H, Luter S, Poteat T, Auerbach JD, Wohl DA. The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy. AIDS research and human retroviruses 2019. PMID: 31608651


  58. Wootton AR, McCuistian C, Legnitto Packard DA, Gruber VA, Saberi P. Overcoming Technological Challenges: Lessons Learned from a Telehealth Counseling Study. Telemedicine journal and e-health : the official journal of the American Telemedicine Association 2019. PMID: 31800368


  60. Reeder C, Neilands TB, Palar K, Saberi P. Food Insecurity and Unmet Needs Among Youth and Young Adults Living With HIV in the San Francisco Bay Area. The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2019. PMID: 31196781


  61. Saberi P, Dawson Rose C, Wootton AR, Ming K, Legnitto D, Jeske M, Pollack LM, Johnson MO, Gruber VA, Neilands TB. Use of technology for delivery of mental health and substance use services to youth living with HIV: a mixed-methods perspective. AIDS care 2019. PMID: 31132864


  63. Saberi P, Ming K, Legnitto D, Neilands TB, Gandhi M, Johnson MO. Feasibility and acceptability of novel methods to estimate antiretroviral adherence: A longitudinal study. PloS one 2019. PMID: 30645641


  64. Saberi P, Neilands TB, Lally MA, Hosek SG, Hightow-Weidman L. The Association between Use of Online Social Networks to Find Sex Partners and Sexually Transmitted Infection Diagnosis among Young Men Who Have Sex with Men and Transgender Women Living with HIV. Journal of the International Association of Providers of AIDS Care 2019. PMID: 31389285


  65. Olea A, Grochowski J, Luetkemeyer AF, Robb V, Saberi P. Role of a clinical pharmacist as part of a multidisciplinary care team in the treatment of HCV in patients living with HIV/HCV coinfection. Integrated pharmacy research & practice 2018. PMID: 30214893


  66. Saberi P, Ming K, Legnitto D, Neilands TB, Gandhi M, Johnson MO. Novel methods to estimate antiretroviral adherence: protocol for a longitudinal study. Patient preference and adherence 2018. PMID: 29950816


  69. Saberi P, Berrean B, Thomas S, Gandhi M, Scott H. A Simple Pre-Exposure Prophylaxis (PrEP) Optimization Intervention for Health Care Providers Prescribing PrEP: Pilot Study. JMIR formative research 2018. PMID: 30637375


  70. Koss CA, Hosek SG, Bacchetti P, Anderson PL, Liu AY, Horng H, Benet LZ, Kuncze K, Louie A, Saberi P, Wilson CM, Gandhi M. Comparison of Measures of Adherence to HIV Preexposure Prophylaxis among Adolescent and Young Men Who Have Sex with Men in the United States. Volume 66 of Issue 2. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017. PMID: 29020194


  71. Saberi P, Neilands TB, Ming K, Johnson MO, Kuncze K, Koss CA, Gandhi M. Strong Correlation Between Concentrations of Antiretrovirals in Home-Collected and Study-Collected Hair Samples: Implications for Adherence Monitoring. Journal of acquired immune deficiency syndromes (1999) 2017. PMID: 28657913


  72. Janet Grochowski, Parya Saberi. Chapter 5: HIV Treatment Failure and Resistance. Psychiatric Research and Clinical Practice 2017. PMID:


  74. van den Berg JJ, Neilands TB, Johnson MO, Chen B, Saberi P. Using Path Analysis to Evaluate the Healthcare Empowerment Model Among Persons Living with HIV for Antiretroviral Therapy Adherence. AIDS patient care and STDs 2016. PMID: 27849372


  75. Saberi P, Siedle-Khan R, Sheon N, Lightfoot M. The Use of Mobile Health Applications Among Youth and Young Adults Living with HIV: Focus Group Findings. Volume 30 of Issue 6. AIDS patient care and STDs 2016. PMID: 27214751


  76. Lippman SA, Shade SB, Sumitani J, DeKadt J, Gilvydis JM, Ratlhagana MJ, Grignon J, Tumbo J, Gilmore H, Agnew E, Saberi P, Barnhart S, Steward WT. Evaluation of short message service and peer navigation to improve engagement in HIV care in South Africa: study protocol for a three-arm cluster randomized controlled trial. Volume 17. Trials 2016. PMID: 26852237


  77. Gilvydis JM, Steward WT, Saberi P, Tumbo J, Sumitani J, Barnhart S, Lippman SA. Need for improvements in clinical practice to retain patients in pre-antiretroviral therapy care: Data from rural clinics in North West Province, South Africa. AIDS care 2015. PMID: 26278130


  79. Saberi P, Catz SL, Leyden WA, Stewart C, Ralston JD, Horberg MA, Grothaus L, Silverberg MJ. Antiretroviral Therapy Adherence and Use of an Electronic Shared Medical Record Among People Living with HIV. AIDS and behavior 2015. PMID: 25572829


  80. Saberi P, Neilands TB, Vittinghoff E, Johnson MO, Chesney M, Cohn SE. Barriers to antiretroviral therapy adherence and plasma HIV RNA suppression among AIDS clinical trials group study participants. AIDS patient care and STDs 2015. PMID: 25615029


  81. Saberi P, Mayer K, Vittinghoff E, Naar-King S. Correlation between use of antiretroviral adherence devices by HIV-infected youth and plasma HIV RNA and self-reported adherence. AIDS and behavior 2015. PMID: 24879628


  83. Parya Saberi, Torsten B. Neilands, Mallory O. Johnson. Association between Dog Guardianship and HIV Clinical Outcomes. Journal of the International Association of Providers of AIDS Care (JIAPAC) 2014. PMID:


  84. Yuan P, Bare MG, Johnson MO, Saberi P. Using online social media for recruitment of human immunodeficiency virus-positive participants: a cross-sectional survey. Journal of medical Internet research 2014. PMID: 24784982


  85. Sevelius JM, Saberi P, Johnson MO. Correlates of antiretroviral adherence and viral load among transgender women living with HIV. AIDS care 2014. PMID: 24646419


  86. Cocohoba J, Dong BJ, Johnson MO, Saberi P. Reporting of critical information in studies of pharmacists in HIV care. The International journal of pharmacy practice 2014. PMID: 24467531


  87. Saberi P, Yuan P, John M, Sheon N, Johnson MO. A pilot study to engage and counsel HIV-positive African American youth via telehealth technology. AIDS patient care and STDs 2013. PMID: 23991691


  88. Saberi P, Comfort M, Sheon N, Johnson MO. Qualitative study of the quality of sleep in marginalized individuals living with HIV. Patient preference and adherence 2013. PMID: 23807839


  90. Saberi P, Gamarel KE, Neilands TB, Comfort M, Sheon N, Darbes LA, Johnson MO. Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study. PloS one 2012. PMID: 23166819


  91. Bruno C, Saberi P. Pharmacists as providers of HIV pre-exposure prophylaxis. International journal of clinical pharmacy 2012. PMID: 23073703


  92. Saberi P, Caswell NH, Jamison R, Estes M, Tulsky JP. Directly observed versus self-administered antiretroviral therapies: preference of HIV-positive jailed inmates in San Francisco. Journal of urban health : bulletin of the New York Academy of Medicine 2012. PMID: 22547327


  93. Saberi P, Comfort M, Johnson MO. The relationship between daily organization and adherence to antiretroviral therapy: a qualitative perspective. Journal of acquired immune deficiency syndromes (1999) 2012. PMID: 22918127


  94. Johnson MO, Sevelius JM, Dilworth SE, Saberi P, Neilands TB. Preliminary support for the construct of health care empowerment in the context of treatment for human immunodeficiency virus. Patient preference and adherence 2012. PMID: 22654510


  95. Saberi P, Dong BJ, Johnson MO, Greenblatt RM, Cocohoba JM. The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review. Patient preference and adherence 2012. PMID: 22536064


  97. Saberi P, Johnson MO, McCulloch CE, Vittinghoff E, Neilands TB. Medication adherence: tailoring the analysis to the data. AIDS and behavior 2011. PMID: 21833689


  98. Saberi P, Neilands TB, Johnson MO. Quality of sleep: associations with antiretroviral nonadherence. AIDS patient care and STDs 2011. PMID: 21770763


  99. Bruno CB, Schapiro JM, Saberi P. An Increase in Serum Creatinine after Initiation of Fenofibrate in an HIV-Infected Individual: A Case Report and Review of the Literature. Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 2011. PMID: 21518854


  100. Saberi P, Ranatunga DK, Quesenberry CP, Silverberg MJ. Clinical implications of the nelfinavir-proton pump inhibitor drug interaction in patients with human immunodeficiency virus. Pharmacotherapy 2011. PMID: 21361735


  101. Ma A, Chen DM, Chau FM, Saberi P. Improving adherence and clinical outcomes through an HIV pharmacist's interventions. AIDS care 2010. PMID: 20640958


  102. Saberi P, Caswell N, Amodio-Groton M, Alpert P. Pharmacy-refill measure of adherence to efavirenz can predict maintenance of HIV viral suppression. AIDS care 2008. PMID: 18576177


  103. Saberi P, Caswell NH, Gruta CI, Tokumoto JN, Dong BJ. Immunologic benefits of enfuvirtide in patients enrolled in a drug assistance program. The Annals of pharmacotherapy 2008. PMID: 18413688


  104. June Riedlinger, Niamh Higgins, Parya Saberi. A Rainforest Expedition with The Student Rainforest Fund. Journal of herbal pharmacotherapy 2005. PMID: